JPH04112860A - N-(substituted benzoyl)-n-(3-chlorophenyl)-beta-alanine and salt thereof - Google Patents
N-(substituted benzoyl)-n-(3-chlorophenyl)-beta-alanine and salt thereofInfo
- Publication number
- JPH04112860A JPH04112860A JP23023490A JP23023490A JPH04112860A JP H04112860 A JPH04112860 A JP H04112860A JP 23023490 A JP23023490 A JP 23023490A JP 23023490 A JP23023490 A JP 23023490A JP H04112860 A JPH04112860 A JP H04112860A
- Authority
- JP
- Japan
- Prior art keywords
- substituted benzoyl
- chlorophenyl
- alanine
- group
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 10
- 229940000635 beta-alanine Drugs 0.000 title abstract description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 title description 7
- -1 N-(substituted benzoyl)-N-(3-chlorophenyl)-beta-alanine Chemical class 0.000 claims abstract description 19
- 229910052783 alkali metal Inorganic materials 0.000 claims abstract description 6
- 150000001340 alkali metals Chemical class 0.000 claims abstract description 5
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims abstract description 5
- 150000001342 alkaline earth metals Chemical class 0.000 claims abstract description 4
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 4
- 150000002367 halogens Chemical class 0.000 claims abstract description 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims abstract description 3
- 150000002892 organic cations Chemical class 0.000 claims abstract description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 abstract description 14
- 239000002934 diuretic Substances 0.000 abstract description 5
- 230000001882 diuretic effect Effects 0.000 abstract description 5
- 239000002585 base Substances 0.000 abstract description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract description 4
- 230000003501 anti-edematous effect Effects 0.000 abstract description 3
- 208000001953 Hypotension Diseases 0.000 abstract description 2
- 208000021822 hypotensive Diseases 0.000 abstract description 2
- 230000001077 hypotensive effect Effects 0.000 abstract description 2
- 235000019260 propionic acid Nutrition 0.000 abstract description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 10
- YHXKNYLHVMSFKC-UHFFFAOYSA-N 3-(3-chloroanilino)propanoic acid Chemical compound OC(=O)CCNC1=CC=CC(Cl)=C1 YHXKNYLHVMSFKC-UHFFFAOYSA-N 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- 239000013078 crystal Substances 0.000 description 5
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 4
- 150000007530 organic bases Chemical class 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 230000003276 anti-hypertensive effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 150000007529 inorganic bases Chemical class 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 206010003445 Ascites Diseases 0.000 description 2
- MFXGIEMGNZTOBV-UHFFFAOYSA-N CC1=CC=CC=C1C(=O)N(CCC(O)=O)C1=CC=CC(Cl)=C1 Chemical compound CC1=CC=CC=C1C(=O)N(CCC(O)=O)C1=CC=CC(Cl)=C1 MFXGIEMGNZTOBV-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 210000003323 beak Anatomy 0.000 description 2
- 150000001793 charged compounds Chemical class 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 2
- HIFJUMGIHIZEPX-UHFFFAOYSA-N sulfuric acid;sulfur trioxide Chemical compound O=S(=O)=O.OS(O)(=O)=O HIFJUMGIHIZEPX-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 238000004065 wastewater treatment Methods 0.000 description 2
- CEOCVKWBUWKBKA-UHFFFAOYSA-N 2,4-dichlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1Cl CEOCVKWBUWKBKA-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical class CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- GPZXFICWCMCQPF-UHFFFAOYSA-N 2-methylbenzoyl chloride Chemical compound CC1=CC=CC=C1C(Cl)=O GPZXFICWCMCQPF-UHFFFAOYSA-N 0.000 description 1
- JHUUPUMBZGWODW-UHFFFAOYSA-N 3,6-dihydro-1,2-dioxine Chemical compound C1OOCC=C1 JHUUPUMBZGWODW-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 101150041968 CDC13 gene Proteins 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical class [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- VMPVEPPRYRXYNP-UHFFFAOYSA-I antimony(5+);pentachloride Chemical compound Cl[Sb](Cl)(Cl)(Cl)Cl VMPVEPPRYRXYNP-UHFFFAOYSA-I 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 150000003939 benzylamines Chemical class 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 150000005332 diethylamines Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 239000011968 lewis acid catalyst Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 229930185107 quinolinone Natural products 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は下記一般式(I)
(式中X、Yはそれぞれ異なる置換基を表わし、炭素原
子数1〜4個の直鎖あるいは分岐鎖の低級アルキル基、
メトキシカルボニル基、ジメチルアミノ基、フェニル基
、シアン基、ニトロ基、トリフルオロメチル基、又はハ
ロゲンであり、n又はmは同時に0ではないが、それぞ
れ0〜2の数であり、2は水素原子、アルカリ金属、ア
ルカリ土類金属、アンモニウム、又は(式中X、Yはそ
れぞれ異なる置換基を表わし、炭素原子数1〜4個の直
鎖あるいは分岐鎖の低級アルキル基、メトキシカルボニ
ル基、ジメチルアミノ基、フェニル基、シアノ基、ニト
ロ基、トリフルオロメチル基、又はハロゲンであり、n
又はmは同時に0ではないが、それぞれO〜2の数であ
り、2は水素原子、アルカリ金属、アルカリ土類金属、
アンモニウム、又は有機カチオンである。)で表わされ
る新規N−(置換ベンゾイル)−N−(3−クロロフェ
ニル)−β−アラニン誘導体に関するものである。Detailed Description of the Invention [Industrial Field of Application] The present invention relates to the following general formula (I) (wherein X and Y each represent a different substituent, and a linear or branched lower alkyl group,
A methoxycarbonyl group, a dimethylamino group, a phenyl group, a cyan group, a nitro group, a trifluoromethyl group, or a halogen, and n or m is not 0 at the same time, but each is a number from 0 to 2, and 2 is a hydrogen atom. , alkali metals, alkaline earth metals, ammonium, or group, phenyl group, cyano group, nitro group, trifluoromethyl group, or halogen, and n
Or m is not 0 at the same time, but is a number of O to 2, and 2 is a hydrogen atom, an alkali metal, an alkaline earth metal,
Ammonium or an organic cation. This invention relates to a novel N-(substituted benzoyl)-N-(3-chlorophenyl)-β-alanine derivative represented by:
これ等誘導体は、例えば特開昭63−239270号公
報又は特開平1−121269号公報に示されるような
、利尿、降圧、抗浮腫及び腹水除去作用を持つ、1−(
置換ベンゾイル)−7−クロロ−2,3−ジヒドロ−4
(LH)−キノリノン誘導体の合成に於ける新規中間体
として極めて有用である。These derivatives have 1-(
(substituted benzoyl)-7-chloro-2,3-dihydro-4
It is extremely useful as a new intermediate in the synthesis of (LH)-quinolinone derivatives.
[従来の技術]
従来、本発明者等が提示する、N−(置換ベンゾイル)
−N−(3−クロロフェニル)−β−アラニンに類似す
る化合物としては、例えば特開昭56−161361号
公報に見られる2−メチルーN−(3−クロロフェニル
)−N−(2−シアノエチル)ベンズアミドのようなニ
トリル体やBull、 Chim、 Farm、、 1
20 (19811及びオランダ国特許NL−6717
715号報に見られるN−(3−クロロフェニル) −
N−ベンゾイル−〇−アラニンエチルエステルのような
エステル体等が知られている。[Prior Art] Conventionally, N-(substituted benzoyl) proposed by the present inventors
Examples of compounds similar to -N-(3-chlorophenyl)-β-alanine include 2-methyl-N-(3-chlorophenyl)-N-(2-cyanoethyl)benzamide, which is found in JP-A-56-161361. Nitriles such as Bull, Chim, Farm, 1
20 (19811 and Dutch patent NL-6717
N-(3-chlorophenyl) found in Report No. 715 -
Ester bodies such as N-benzoyl-〇-alanine ethyl ester are known.
又、本発明化合物が産業上に於いて利用される1−(置
換ベンゾイル)−7−クロロ−23−ジヒドロ−4(L
H)−キノリノン誘導体の合成については、例えば特公
平1−55270号公報に見られるような方法で、3−
(3クロロアニリノ)プロピオン酸を高濃度の発煙硫酸
を用いて環化させ、しかる後得られた7−クロロ−2,
3−ジヒドロ−4(IH)−キノリノンを種々置換ベン
ゾイルハライドと反応させ、更に目的とする生理活性作
用を持つ誘導体へと転換させる方法が知られている(特
開昭63−239270号公報)。In addition, the compound of the present invention can be used in industrial applications such as 1-(substituted benzoyl)-7-chloro-23-dihydro-4(L
Regarding the synthesis of H)-quinolinone derivatives, 3-
(3-chloroanilino)propionic acid was cyclized using highly concentrated oleum, and the resulting 7-chloro-2,
A method is known in which 3-dihydro-4(IH)-quinolinone is reacted with various substituted benzoyl halides and further converted into a derivative having the desired physiologically active action (Japanese Patent Laid-Open Publication No. 239270/1983).
[発明が解決しようとする課題]
しかしながら、前記7−り四ロー2,3−ジヒドロ−4
(LH)−キノリノンを特公平1−55270号公報に
見られるような方法で工業的に製造する為には、危険性
が高く、又廃水処理上も問題となる発煙硫酸を大量に使
用せねばならず、この事は工業的見地からは極めて問題
となる。7−クロロ−2,3−ジヒドロ−4(IH)−
キノリノンを合成する為の手法としては、その他にも特
公平2−22750号公報のようにHF/BFxを環化
縮合剤として用いる方法、又特開昭60−87266号
及び同60−87267号公報のように一旦ホスゲンを
反応させて、N位を保護してから環化させる方法等が提
案されているが、これ等方法も同様に危険性の高いHF
/ BF、やホスゲンを使用する為やはり工業的には不
向きである。[Problems to be Solved by the Invention] However, the above-mentioned 7-tri-4-2,3-dihydro-4
In order to industrially produce (LH)-quinolinone using the method described in Japanese Patent Publication No. 1-55270, it is necessary to use large amounts of fuming sulfuric acid, which is highly dangerous and also poses problems in terms of wastewater treatment. This is extremely problematic from an industrial standpoint. 7-chloro-2,3-dihydro-4(IH)-
Other methods for synthesizing quinolinone include a method using HF/BFx as a cyclization condensation agent as described in Japanese Patent Publication No. 2-22750, and Japanese Patent Application Laid-open Nos. 60-87266 and 60-87267. A method has been proposed in which phosgene is first reacted, the N-position is protected, and then cyclized, as in
/ Because it uses BF and phosgene, it is not suitable for industrial use.
これ等の問題点から、特開昭63−239270号公報
等に提案される、1−(置換ベンゾイル)−7−クロロ
−2,3−ジヒドロ−4(IH)キノリノン誘導体を工
業的に製造する為には別途の中間体及び製造法が切望さ
れていた。In view of these problems, industrial production of 1-(substituted benzoyl)-7-chloro-2,3-dihydro-4(IH) quinolinone derivatives is proposed in JP-A No. 63-239270. For this purpose, separate intermediates and production methods were desperately needed.
〔課題を解決するための手段]
本発明者等は前記問題点を解決する為に鋭意検討した結
果、それ自体新規であるN−(置換ベンゾイル)−N−
(3−クロロフェニル)β−アラニン及びその塩を見出
すと共に、これ等誘導体を用いて工業的にも極めて有利
な方法で特公昭63−239270号公報に提案される
1−(置換ベンゾイル)−7−クロロ−2゜3−ジヒド
ロ−4(IH)−キノリノン誘導体が製造され得る事を
見出した。[Means for Solving the Problems] As a result of intensive studies to solve the above-mentioned problems, the present inventors discovered that N-(substituted benzoyl)-N- is novel in itself.
(3-chlorophenyl)β-alanine and its salts were discovered, and 1-(substituted benzoyl)-7- was proposed in Japanese Patent Publication No. 63-239270 using these derivatives in an industrially very advantageous method. It has been found that chloro-2°3-dihydro-4(IH)-quinolinone derivatives can be prepared.
即ち、本発明は下記一般式(I)
(式中、X、Y、n、m及びZについては前記定義に準
する。)で表わされる化合物を提供する事により、利尿
、降圧、抗浮腫及び腹水除去作用を持つ1−(置換ベン
ゾイル)−7−クロロ−2,3−ジヒドロ−4(LH)
−キノリノン誘導体を工業的に極めて有利な方法で製造
する事を可能としたものである。That is, the present invention provides diuretic, antihypertensive, antiedema and 1-(substituted benzoyl)-7-chloro-2,3-dihydro-4 (LH), which has ascites removal effect
-It has made it possible to produce quinolinone derivatives by an industrially extremely advantageous method.
−F]9式(I)の化合物の合成は、それ自体既知の化
合物である3−(3−クロロアニリノ)プロピオン酸を
出発原料とし、これを有機又は無機塩基及び反応に関与
しない極性又は非極性溶媒の存在下、所望する置換ベン
ゾイルハライドと反応させる事により達成出来る。-F]9 The synthesis of the compound of formula (I) uses 3-(3-chloroanilino)propionic acid, which is a known compound per se, as a starting material, and an organic or inorganic base and a polar or non-polar base that does not participate in the reaction. This can be achieved by reacting with a desired substituted benzoyl halide in the presence of a solvent.
この時使用される有機塩基としては、例えばトリエチル
アミン、トリーn−ブチルアミン、N、N−ジメチルア
ニリン、ピリジン、等の脂肪族及び芳香族の第3級アミ
ンが挙げられ、無機塩基としてはアルカリ金属、アルカ
リ土類金属の水酸化物、炭酸塩、及び重炭酸塩を挙げる
ことが出来る。Examples of organic bases used at this time include aliphatic and aromatic tertiary amines such as triethylamine, tri-n-butylamine, N,N-dimethylaniline, and pyridine; examples of inorganic bases include alkali metals, Mention may be made of alkaline earth metal hydroxides, carbonates and bicarbonates.
使用する溶媒としては、反応に関与しなければ特に限定
されるものではないが、例えばトルエン、モノクロロベ
ンゼン、ジクロロメタン等の非極性溶媒及びテトラヒド
ロフラン、■、4−ジオキサン、アセトニトリル等の極
性溶媒及び水を挙げることが出来、非極性溶媒と水との
不均一系や水溶性溶媒と水のような均−系を採る事も可
能である。The solvent used is not particularly limited as long as it does not participate in the reaction, but examples include non-polar solvents such as toluene, monochlorobenzene, dichloromethane, polar solvents such as tetrahydrofuran, 4-dioxane, acetonitrile, and water. It is also possible to adopt a heterogeneous system of a nonpolar solvent and water or a homogeneous system such as a water-soluble solvent and water.
使用する置換ベンゾイルハライド類の量は、原料の3−
(3−クロロアニリノ)プロピオン酸に対して、理論量
近辺の0.7〜1,3倍モル比、好ましくは 09〜1
.1倍モル比であり、使用する有機又は無機塩基の量は
同様に原料の3−(3−クロロアニリノ)プロピオン酸
に対して、理論量ないし若干過剰量の1.0〜1.5倍
モル比、好ましくは 1.0〜1.1倍モル比である。The amount of substituted benzoyl halides used is based on the 3-
(3-chloroanilino)propionic acid, 0.7 to 1.3 times the molar ratio near the theoretical amount, preferably 09 to 1
.. Similarly, the amount of organic or inorganic base used is a 1.0 to 1.5 times molar ratio of the theoretical amount to a slight excess of 3-(3-chloroanilino)propionic acid as the raw material. , preferably 1.0 to 1.1 times the molar ratio.
溶媒の使用量は、やはり原料の酸に対して1〜30重量
倍、好ましくは3〜15倍である。The amount of the solvent to be used is 1 to 30 times, preferably 3 to 15 times, the weight of the raw acid.
反応温度は、−10〜50℃の範囲で行なわれるが、好
ましくは0〜30℃であり、通常は適当な温度を維持す
る為に置換ベンゾイルハライド類から3−〔3−クロロ
アニリノ)プロピオン酸と塩基の溶媒希釈物を滴下する
事が望ましい。The reaction temperature is carried out in the range of -10 to 50°C, preferably 0 to 30°C, and usually the substituted benzoyl halides are mixed with 3-[3-chloroanilino)propionic acid in order to maintain an appropriate temperature. It is desirable to drop a solvent dilution of the base.
一般式(I)で表わされる本発明の化合物は、あらゆる
塩基との塩の形にする事が出来る。具体的な塩の形とし
ては5例えばナトリウム塩、カリウム塩などのアルカリ
金属塩、カルシウム塩などのアルカリ土類金属塩、アン
モニウム塩、ベンジルアミン塩、ジエチルアミン塩など
の有機塩基との塩、及びアルギニン塩、リジン塩などの
アミノ酸との塩が挙げられる。The compound of the present invention represented by general formula (I) can be in the form of a salt with any base. Specific salt forms include 5, for example, alkali metal salts such as sodium salts and potassium salts, alkaline earth metal salts such as calcium salts, salts with organic bases such as ammonium salts, benzylamine salts, and diethylamine salts, and arginine salts. Examples include salts and salts with amino acids such as lysine salts.
このようにして得られたN−(置換ベンゾイル)−N−
(3−クロロフェニル)−β−アラニン類は必要ならば
再結晶、カラムクロマトグラフィー等の精製操作を加え
、利尿、降圧等の作用を持つ、1−(置換ベンゾイル)
−7−り四ロー2,3−ジヒドロ−4(LH)−キノリ
ノン誘導体へと以下の方法にて容易に転換される。N-(substituted benzoyl)-N- thus obtained
(3-chlorophenyl)-β-alanine is purified by recrystallization, column chromatography, etc., if necessary, to produce 1-(substituted benzoyl), which has diuretic, hypotensive, etc.
It can be easily converted into a -7-di4-2,3-dihydro-4(LH)-quinolinone derivative by the following method.
即ち、合成されたN−(置換ベンゾイル)N−(3−ク
ロロフェニル)−β−アラニン及びその塩は塩化チオニ
ル、五塩化リン、オキシ塩化リン又は必要ならばホスゲ
ン等の試剤によりN−装置mベンゾイル)−N−(3−
クロロフェニル)−β−アラニルクロライドへと転換さ
れ、更にこの酸クロライド誘導体は、無水塩化アルミニ
ウム、塩化第二鉄、五塩化アンチモン等のルイス酸触媒
の存在下、分子内のフリーデルクラフッ反応により容易
に環化され、1−(置換ベンゾイル)−7−クロロ−2
,3−ジヒドロ−4(IH)−キノリノンへと導がれる
。That is, the synthesized N-(substituted benzoyl)N-(3-chlorophenyl)-β-alanine and its salts are converted into N-substituted benzoyl by using reagents such as thionyl chloride, phosphorus pentachloride, phosphorus oxychloride, or phosgene if necessary. )-N-(3-
(chlorophenyl)-β-alanyl chloride, and further, this acid chloride derivative is subjected to an intramolecular Friedel-Crach reaction in the presence of a Lewis acid catalyst such as anhydrous aluminum chloride, ferric chloride, or antimony pentachloride. Easily cyclized, 1-(substituted benzoyl)-7-chloro-2
, 3-dihydro-4(IH)-quinolinone.
更にこのキノリノン誘導体は特開昭63−239270
号公報等に記載されている方法によって、利尿、降圧作
用等を発現する、l−(置換ベンゾイル)−7−クロロ
−2,3−ジヒドロ−4(LH)−キノリノン−4−オ
キシム誘導体へと転換されるものである。Furthermore, this quinolinone derivative is disclosed in JP-A No. 63-239270.
1-(substituted benzoyl)-7-chloro-2,3-dihydro-4(LH)-quinolinone-4-oxime derivative, which exhibits diuretic, antihypertensive effects, etc., by the method described in the above publication. It is something that can be transformed.
本発明に於いて置換ベンゾイル部分は、特開昭63−2
39270号又は特開平1−121269号公報に記載
された化合物の1位アシル基でもよく、得られる化合物
は特開昭63−239270号又は特開平1−1212
69号公報記載の化合物の合成に応用出来る。In the present invention, the substituted benzoyl moiety is
The 1-position acyl group of the compound described in JP-A No. 39270 or JP-A-1-121269 may also be used, and the resulting compound may be the acyl group at the 1-position of the compound described in JP-A-63-239270 or JP-A-1-1212.
It can be applied to the synthesis of the compounds described in No. 69.
[発明の効果]
本発明の化合物を用いた場合、公知技術に見られるよう
な発煙硫酸、ホスゲンなどの危険性の高い試薬を使う必
要がないので、1−(置換ベンゾイル)−7−クロロ−
2,3−ジヒドロ−4(LH)−キノリノン誘導体を、
安全かつ廃水処理などの問題を生ずることなく、工業的
に製造することが出来るので極めて有用である。[Effects of the Invention] When the compound of the present invention is used, there is no need to use highly dangerous reagents such as fuming sulfuric acid and phosgene, which are found in known techniques.
2,3-dihydro-4(LH)-quinolinone derivative,
It is extremely useful because it can be produced industrially safely and without causing problems such as wastewater treatment.
本発明の化合物は特開昭63−239270号公報に開
示されている、利尿、降圧、抗浮腫及び腹水除去作用を
持つ、1−(置換ベンゾイル〕−7−クロロ−2,3−
ジヒドロ−4(IH)−キノリノン誘導体の合成に応用
8来るので、該誘導体の合成に於ける新規中間体として
極めて有用である。The compound of the present invention is a compound of 1-(substituted benzoyl)-7-chloro-2,3- which has diuretic, antihypertensive, anti-edema and ascites removal activity, which is disclosed in JP-A No. 63-239270.
Since it has many applications in the synthesis of dihydro-4(IH)-quinolinone derivatives, it is extremely useful as a new intermediate in the synthesis of said derivatives.
[実施例] 以下に本発明を説明する実施例を示す。[Example] Examples illustrating the present invention are shown below.
実施例I
N−2−メチルベンゾイル −N−(3−クロロフェニ
ル)−β−アラニン
3−(3−クロロアニリノ)プロピオン酸6gをジクロ
ロメタン40mQに忍解し、5〜10°Cの温度でトリ
エチルアミン3.03gを加えた。Example I 6 g of N-2-methylbenzoyl-N-(3-chlorophenyl)-β-alanine 3-(3-chloroanilino)propionic acid are dissolved in 40 mQ of dichloromethane and triethylamine 3. 03g was added.
引き続き同温度てo−トルイル酸クロライド4.4gを
約30分間で滴下した後、反応液を室温に戻しそのまま
2時間撹拌を行った。終了液をlN−HCl230mI
2中に注加し、撹拌洗浄後ジクロロメタン層を分液した
。同層を更に水洗分液後、無水硫酸マグネシウムにて乾
燥しジクロロメタンを減圧下留去した。留去残渣は室温
放置により徐々に結晶化した。析出結晶を少量のエーテ
ルにて分散洗浄後、濾過乾燥する墨により、目的とする
N−(2−メチルベンゾイル)−N−(3−クロロフェ
ニル)−β−アラニンの白色結晶を6.7g (得率7
4%)得た。Subsequently, 4.4 g of o-toluic acid chloride was added dropwise over about 30 minutes at the same temperature, and then the reaction solution was returned to room temperature and stirred for 2 hours. Add the finished solution to 230 mI of 1N-HCl.
After stirring and washing, the dichloromethane layer was separated. The same layer was further washed with water and separated, then dried over anhydrous magnesium sulfate, and dichloromethane was distilled off under reduced pressure. The distilled residue gradually crystallized by standing at room temperature. After dispersing and washing the precipitated crystals with a small amount of ether, filtration and drying were carried out to obtain 6.7 g of the desired white crystals of N-(2-methylbenzoyl)-N-(3-chlorophenyl)-β-alanine. rate 7
4%) was obtained.
m、p、 : 110.5〜112.5℃m/z:
317(分子イオンビーク)
’H−NMR(CDC1,) 、 δ(ppm )2
、34 (s、 3H1、2,73(t、 21(1。m, p,: 110.5-112.5°C m/z:
317 (molecular ion beak) 'H-NMR (CDC1,), δ (ppm)2
, 34 (s, 3H1, 2,73 (t, 21 (1.
4、20 ft、 2H) 、 7.05〜7.30
(m、 8H)”C−NMR(CDC1,)、 δ
(ppm):19.3. 32.3. .45.5
゜125.2. 125.9. 127.4゜12
7.5. 127.6. 129.1゜129.9
. 130.3. 134.4゜134.7.
135.4. 142.9171.3. 176.
1゜
I R(KBr)、 cm−’:
1735、 1615. 1590. 15B0
゜1480、 1415. 1250. 123
0実施例2
3−(3−クロロアニリノ)プロピオン酸6gをI N
−N a OH30+nI2に攪拌溶解し、5〜10
℃の温度で2.4−ジクロロベンゾイルクロライド 5
.97 gの60m 12テトラヒドロフラン溶液を2
時間かけて滴下した。滴下終了後テトラヒドロフランを
減圧下留去し、残>mを2N−HCβでpHを約1とし
た。ジクロロメタン約60m g、を添加し、析出して
いるoil (油)分を抽出分液した後、更に水洗し、
無水硫酸マグネシウムにて乾燥してから減圧下ジクロロ
メタンを留去した。4, 20 ft, 2H), 7.05-7.30
(m, 8H)”C-NMR (CDC1,), δ
(ppm): 19.3. 32.3. .. 45.5
゜125.2. 125.9. 127.4°12
7.5. 127.6. 129.1°129.9
.. 130.3. 134.4°134.7.
135.4. 142.9171.3. 176.
1°I R (KBr), cm-': 1735, 1615. 1590. 15B0
゜1480, 1415. 1250. 123
Example 2 6 g of 3-(3-chloroanilino)propionic acid was added to IN
-N a OH30 + nI2 with stirring, 5 to 10
2.4-dichlorobenzoyl chloride at a temperature of 5 °C
.. 97 g of 60 m 12 tetrahydrofuran solution
It dripped over time. After completion of the dropwise addition, tetrahydrofuran was distilled off under reduced pressure, and the remaining residue was adjusted to pH approximately 1 with 2N-HCβ. About 60 mg of dichloromethane was added, the precipitated oil was extracted and separated, and then washed with water.
After drying over anhydrous magnesium sulfate, dichloromethane was distilled off under reduced pressure.
残oilを酢酸エチル/n−ヘキサン/酢酸=10/2
0/1にてシリカゲルカラムクロマトグラフィー精製し
目的とするN−(2,4−ジクロロベンゾイル)−N−
(3−クロロフェニル)−β−アラニンな白色結晶とし
て5.87 g(得率55.3%)得た。The remaining oil was mixed with ethyl acetate/n-hexane/acetic acid = 10/2.
The target N-(2,4-dichlorobenzoyl)-N- was purified by silica gel column chromatography at 0/1.
5.87 g (yield: 55.3%) of white crystals of (3-chlorophenyl)-β-alanine were obtained.
m、p、 : 112.5〜113.5℃m/z:
371(分子イオンビーク)
’H−NMR(CDC1,) 、δ(ppm ) :
2.76(t、2H)、 4.20ft、2H)。m, p,: 112.5-113.5°C m/z:
371 (molecular ion beak) 'H-NMR (CDC1,), δ (ppm):
2.76 (t, 2H), 4.20ft, 2H).
?、 HN3.23 (m、 7H)
”CNMR(CDCIs ) 、δ(ppm ) :
32.1. 45.4. 126.1゜126.8.
127.8
129.4. 129.5゜
131.4. 134.1
135.5. 142.1゜
IR(KBr)、 cm
1730、 1660゜
14B0. 1440゜
128.2゜
134.7゜
167.2゜
1615゜
1590゜
1405゜
1320゜
実施例3〜19
実施例1と同様の方法にて次表に示す化合物を得た。? , HN3.23 (m, 7H) CNMR (CDCIs), δ (ppm):
32.1. 45.4. 126.1°126.8.
127.8 129.4. 129.5°131.4. 134.1 135.5. 142.1°IR (KBr), cm 1730, 1660°14B0. 1440° 128.2° 134.7° 167.2° 1615° 1590° 1405° 1320° Examples 3 to 19 In the same manner as in Example 1, the compounds shown in the following table were obtained.
一般式(IA)
参考例1
N−(2−メチルベンゾイル)−N−(3−クロロフェ
ニル)−β−アラニン117gを1.2−ジクロロエタ
ン30n+J2に分散し、微少量のDMFを加え氷冷し
た。塩化チオニル5.3gを注加した後、徐々に昇温し
50°Cで約2時間撹拌した0反応終了液から減圧下1
,2−ジクロロエタン及び少過剰の塩化チオニルを除き
、淡黄色oi1のN−(2−メチルベンゾイル)N−(
3−クロロフェニル)−β−アラニルクロライド12.
7gを得た。General Formula (IA) Reference Example 1 117 g of N-(2-methylbenzoyl)-N-(3-chlorophenyl)-β-alanine was dispersed in 1,2-dichloroethane 30n+J2, and a small amount of DMF was added and cooled on ice. After adding 5.3 g of thionyl chloride, the temperature was gradually raised and stirred at 50°C for about 2 hours.
, 2-dichloroethane and a small excess of thionyl chloride were removed to give pale yellow oi1 N-(2-methylbenzoyl)N-(
3-chlorophenyl)-β-alanyl chloride 12.
7g was obtained.
’H−NM R(CDC1,) 、 δ(ppm )
:2.33(s、3H1,3,00ft、2H)。'H-NMR (CDC1,), δ (ppm)
:2.33(s, 3H1, 3,00ft, 2H).
4.21ft、2H)、 6.97〜?、11(m、8
H)”C−N M R(CDCIs ) 、 δ(pp
m ) :19.4. 32.3. 45.3゜
125.2. 125.8. 127.2゜127.4
. 127.6. 129.2゜13、、O,l。4.21ft, 2H), 6.97~? , 11 (m, 8
H)”C-NMR(CDCIs), δ(pp
m): 19.4. 32.3. 45.3°125.2. 125.8. 127.2°127.4
.. 127.6. 129.2°13,, O, l.
134.9゜
171.1゜
I R,(液膜)
1780゜
1430゜
参考例2
130.4゜
135.1゜
171.8
m
1370゜
134.6
142.8゜
1580゜
1470゜
参考例1で合成したN−(2−メチルベンゾイル)−N
−(3−10ロフエニル)−β−アラニルクロライド
11.1 gを1,72−ジクロロエタン50+nJ2
に溶解し、水冷下、無水塩化アルミニウム 10.13
gを添加した。撹拌下徐々に昇温し35〜40°Cで
7時間反応させた。反応後、反応液を氷塩酸水に注加し
、しばらく洗浄後有機層を分液した。更に希塩酸水、飽
和食塩水、飽和重曹水、飽和食塩水の順で有機層を洗浄
し、無水硫酸マグネシウムで乾燥後、1.2−ジクロロ
エタンを減圧下留去した。残oilをジイソプロピルエ
ーテルで処理し、析出結晶を濾過、洗浄乾燥し黄色結晶
の1−(2−メチルベンゾイル)−7−クロロ−2,3
−ジヒドロ−4(IH)−キノリノン7.8g (得率
788%)を得た。134.9° 171.1° I R, (liquid film) 1780° 1430° Reference Example 2 130.4° 135.1° 171.8 m 1370° 134.6 142.8° 1580° 1470° Reference Example 1 N-(2-methylbenzoyl)-N synthesized by
-(3-10lophenyl)-β-alanyl chloride
11.1 g of 1,72-dichloroethane 50+nJ2
Anhydrous aluminum chloride dissolved in water and cooled with water 10.13
g was added. The temperature was gradually raised while stirring, and the reaction was carried out at 35 to 40°C for 7 hours. After the reaction, the reaction solution was poured into iced hydrochloric acid water, washed for a while, and then the organic layer was separated. Furthermore, the organic layer was washed with diluted hydrochloric acid, saturated brine, saturated sodium bicarbonate, and saturated brine in this order, dried over anhydrous magnesium sulfate, and then 1,2-dichloroethane was distilled off under reduced pressure. The remaining oil was treated with diisopropyl ether, and the precipitated crystals were filtered, washed and dried to give yellow crystals of 1-(2-methylbenzoyl)-7-chloro-2,3.
-dihydro-4(IH)-quinolinone 7.8 g (yield 788%) was obtained.
m、p、: 106〜108℃
I R(KBr) 、 cm−’:
1695、 1655. 1405. 1380゜H−
NM R(CDC13) 、 δ(ppm ) :
2、34 fs、 3H] 、 2.80 (t、 2
)1) 。m, p,: 106-108°C IR(KBr), cm-': 1695, 1655. 1405. 1380°H-
NMR (CDC13), δ (ppm):
2, 34 fs, 3H], 2.80 (t, 2
)1).
4.16(t、2H1,7,17〜7.36(m、6H
1,7,96(d、 IH)
特許出願人 保土谷化学工業株式会社
同 持田製薬株式会社
(ばか2名)4.16(t, 2H1,7,17~7.36(m, 6H
1,7,96 (d, IH) Patent applicant Hodogaya Chemical Industry Co., Ltd. Mochida Pharmaceutical Co., Ltd. (2 idiots)
Claims (1)
子数1〜4個の直鎖あるいは分岐鎖の低級アルキル基、
メトキシカルボニル基、ジメチルアミノ基、フェニル基
、シアノ基、ニトロ基、トリフルオロメチル基、又はハ
ロゲンであり、n又はmは同時に0ではないが、それぞ
れ0〜2の数であり、Zは水素原子、アルカリ金属、ア
ルカリ土類金属、アンモニウム、又は有機カチオンであ
る。)で表わされる新規N−(置換ベンゾイル)−N−
(3−クロロフェニル)−β−アラニン及びその塩。[Claims] The following general formula (I) ▲There are mathematical formulas, chemical formulas, tables, etc.▼(I) (In the formula, X and Y each represent a different substituent, and a straight chain or branched lower alkyl group,
A methoxycarbonyl group, a dimethylamino group, a phenyl group, a cyano group, a nitro group, a trifluoromethyl group, or a halogen, n or m is not 0 at the same time, but each is a number from 0 to 2, and Z is a hydrogen atom , an alkali metal, an alkaline earth metal, ammonium, or an organic cation. ) Novel N-(substituted benzoyl)-N-
(3-chlorophenyl)-β-alanine and its salts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23023490A JP2694476B2 (en) | 1990-08-31 | 1990-08-31 | N- (substituted benzoyl) -N- (3-chlorophenyl) -β-alanine and salts thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP23023490A JP2694476B2 (en) | 1990-08-31 | 1990-08-31 | N- (substituted benzoyl) -N- (3-chlorophenyl) -β-alanine and salts thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04112860A true JPH04112860A (en) | 1992-04-14 |
JP2694476B2 JP2694476B2 (en) | 1997-12-24 |
Family
ID=16904638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP23023490A Expired - Lifetime JP2694476B2 (en) | 1990-08-31 | 1990-08-31 | N- (substituted benzoyl) -N- (3-chlorophenyl) -β-alanine and salts thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2694476B2 (en) |
-
1990
- 1990-08-31 JP JP23023490A patent/JP2694476B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP2694476B2 (en) | 1997-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3526581B2 (en) | Method for producing citalopram | |
US5034541A (en) | Method of preparing 1-phenyl-1-diethylaminocarbonyl-2-phthalimidomethyl-cyclopropane-z | |
WO2017157352A1 (en) | A preparation method of diastereomerically pure tenofovir alafenamide or its salts | |
JP2003506425A (en) | Method for producing nitroxyalkyl ester of naproxen | |
JP2020528064A (en) | Process for preparing and purifying the LFA-1 antagonist refitegrass | |
DK175838B1 (en) | Process for the preparation of 2,6-dichlorodiphenylamine acetic acid derivatives | |
KR100251522B1 (en) | Pyrrolo[3,2-c]quinoline derivatives containing haloalkoxy group and pharmaceutically acceptable salts thereof | |
JPH04112860A (en) | N-(substituted benzoyl)-n-(3-chlorophenyl)-beta-alanine and salt thereof | |
JP3272819B2 (en) | Method for producing benzoic acid and nicotinic acid derivatives | |
CN112272665A (en) | Process for preparing sitagliptin | |
US7094914B2 (en) | Process for producing chromone compound | |
JP3207018B2 (en) | Method for producing benzylsuccinic acid derivative and intermediate for producing the same | |
JPH07242670A (en) | Pyrrolo(3,2-e)pyrazolo(1,5-a)pyrimidine derivative and circulatory disease-treating agent using the same | |
CZ239496A3 (en) | Substituted 4h-pyrans, process of their preparation, their use and pharmaceutical composition containing thereof | |
CA3162060A1 (en) | A process for preparation of 3,6-dichlorocyano pyrazine, 3,6-dioxopiperazine derivatives and production of favipiravir thereof | |
JPS6324994B2 (en) | ||
JP2004231521A (en) | Method for synthesizing 3-chloro-5-nitrotoluene | |
CN114560862A (en) | Synthesis method of pyrrolo [1,2-A ] quinoxaline-4 (5H) -ketone and derivative thereof | |
JPH0812658A (en) | Production of sydnones | |
JP3332171B2 (en) | Method for producing thieno [3,2-b] pyridine derivative | |
JPH07267950A (en) | Production of 5-chloro-n-(4,5-dihydro-1h-imidazol-2-yl)-2,1,3-benzothiadiazole-4-amine or its acid-added salt | |
JPH0827152A (en) | Method for removing silyl group of silyl ether compound of carbapenems | |
JPH0625208A (en) | Reagent for resolving racemic modification, its production and its use | |
JPS5852995B2 (en) | Method for producing furfural derivatives | |
JP2002047269A (en) | Method for producing heterocyclic compound and intermediate therefor |